Latest news with #DanishCapitalMarketsAct
Yahoo
11-07-2025
- Business
- Yahoo
DSV, 1158
Company Announcement No. 1158 Pursuant to section 30 of the Danish Capital Markets Act please note that Agility Public Warehousing Company K.S.C.P ('Agility K.S.C.P') informed DSV A/S (DSV) that the Agility Group has reorganized its holding of shares/voting rights according to section 38 of the Danish Capital Markets Act in DSV. Agility K.S.C.P hold shares/voting in DSV A/S via their subsidiary Agility Global PLC. Due to the internal reorganization in Agility Group, the ultimate beneficial ownership of the shares/voting rights in DSV A/S shifts from Agility K.S.C.P to Agility Global PLC. As of 4 July 2025, the Agility Group's shareholding in DSV A/S remains unaffected, and the Agility Group still hold - directly or indirectly - 19,304,348 shares/voting rights in DSV A/S, corresponding to 8.03% of the entire share capital and voting rights in DSV A/S. ContactsInvestor Relations: Stig Frederiksen, tel. +45 43 20 36 38, Plenborg, tel. +45 43 20 33 73, Yours sincerely,DSV A/S Attachment 1158 - Announcement (11.07.2025) - MAJOR SHAREHOLDER ANNOUNCEMENTSign in to access your portfolio
Associated Press
30-06-2025
- Business
- Associated Press
Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ('the Company' or 'Zealand Pharma') (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end of a calendar month during which changes to its share capital have occurred. In Company Announcement No. 14 / 2025 dated June 6, 2025, Zealand Pharma announced a share capital increase due to the exercise of employee warrants. Following this announcement, the table below details the total number of shares and voting rights in Zealand Pharma as of June 30, 2025. The Company's Articles of Association are available on the Company's website # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ('Zealand') is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharmaceutical companies as well as commercial partnerships for its marketed products. Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States. For more information about Zealand's business and activities, please visit Contact Adam Lange (Investors) Vice President, Investor Relations [email protected] Neshat Ahmadi (Investors) Investor Relations Manager [email protected] Anna Krassowska (Investors and Media) Vice President, Investor Relations & Corporate Communications [email protected]
Yahoo
10-06-2025
- Business
- Yahoo
Park Street A/S - total number of voting rights and capital resulting from the capital reduction
Park Street A/S Total number of voting rights and capital and changes in company's treasury shares Park Street A/S - total number of voting rights and capital resulting from the capital reduction With reference to the company announcement on 28 April 2025 regarding the general meeting's approval of a share capital reduction, Park Street A/S hereby announces that completion of the share capital reduction has been registered with the Danish Business Authority with effect on 10 June 2025. The cancellation of the 1,629,459 treasury A-shares (the listed shares) will be removed from trading on Nasdaq Copenhagen in the coming days. The total nominal value of the share capital reduction is DKK 13,794,324 corresponding to 1,629,459 A-shares (listed) and 12,164,865 B-shares (not listed). Accordingly, Park Street A/S' share capital is then reduced from DKK 57,175,572 to DKK 43,381,248. Consequently, Park Street A/S no longer holds any class A treasury shares nor any class B treasury shares. Prior to the share capital reduction, the treasury shares held by Park Street A/S corresponded to 24.13% of the company's total share capital. In accordance with section 31 of the Danish Capital Market Act, it is hereby announced that Park Street A/S, following registration of the share capital reduction, holds 0% of the total share capital. Finally, in accordance with section 32 of the Danish Capital Markets Act, Park Street A/S hereby announces that its share capital then amounts to a nominal value of DKK 43,381,248, corresponding to 43,381,248 shares of nominally DKK 1 each and a total of 43,381,248 voting rights. The share capital is divided into 11,198,178 class A shares and 32,183,070 class B shares of nominally DKK 1 each. For further information please contact Pradeep Pattem, CEO at parkstreet@ Company Website: Telephone Number: +45 33 33 93 03Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-06-2025
- Business
- Yahoo
Notification of major shareholding
Park Street A/S Major shareholder announcements Notification of major shareholding With reference to section 30 of the Danish Capital Markets Act, Park Street A/S (the "Company") hereby announces the below developments in the direct and indirect holdings of share capital and voting rights in the Company by Park Street Asset Management Ltd. With reference to the now completed capital reduction on 10 June 2025, approved by the general meeting on 28 April 2025, Park Street Asset Management Ltd ("PSAM") today notified the Company that PSAM's direct and indirect ownership in the Company has increased from 71.78% to 94.61%. The number of shares held by PSAM remains unchanged; the adjustment is solely a result of the capital reduction Following the capital reduction, as of 10 June 2025, PSAM still directly holds a total of 41,043,493 shares, comprising 8,860,423 A-shares and 32,183,070 B-shares For further information please contact Pradeep Pattem, CEO at parkstreet@ Company Website: Telephone Number: +45 33 33 93 03Sign in to access your portfolio
Yahoo
28-05-2025
- Business
- Yahoo
Netcompany- Major shareholder announcement
Company announcement No. 14/2025 28 May 2025Netcompany Group A/S ("Netcompany") hereby announces the following notification received pursuant to section 38 of the Danish Capital Markets Act from Danske Bank A/S, regarding their direct and indirect holdings and voting rights in Netcompany. On 27 May 2025 Danske Bank A/S informed Netcompany, that Danske Bank A/S on 14 March 2023 directly and indirectly via Danica Pension Livsforsikringsaktieselskab, Investeringsforeningen DI, Investeringsforeningen DI Select, Kapitalforeningen DI Institutional, Danske Bank A/S, and Sicav Capital LUX controlled 2,465,823 voting rights corresponding to 4.93% of the total voting rights in the Company. Their direct and indirect voting rights at the previous announcement was 5.00%. This announcement is in accordance with section 30 of the Danish Capital Markets Act. For further information, please see the attached notification form. Additional informationFor additional information, please contact: Netcompany Group A/SThomas Johansen, CFO, + 45 51 19 32 24Frederikke Linde, Head of IR, +45 60 62 60 87 Attachments 14. Notification form DB 14. Netcompany - Major shareholder announcement - DBError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
